Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2022 Annual Meeting of Stockholders of Rocket Pharmaceuticals, Inc. (the "Company"), was held on June 13, 2022 (the "Annual Meeting"). At the Annual Meeting, there were present, in person or by proxy, holders of 55,510,402 shares of common stock, or approximately 86.03% of the total outstanding shares eligible to be voted. The holders present voted on the three proposals presented at the Annual Meeting as follows.

Proposal One - Election of Directors

The Company's stockholders approved the election of nine directors to the Company's Board of Directors ("Board") by the following votes:



Nominee                      Votes For  Votes Withheld Broker Non-Votes
Elisabeth Björk, M.D., Ph.D. 47,847,554    561,549        7,101,299
Carsten Boess                47,072,823   1,336,280       7,101,299
Pedro Granadillo             43,070,107   5,338,996       7,101,299
Gotham Makker, M.D.          41,028,492   7,380,611       7,101,299
Fady Malik, M.D., Ph.D.      48,162,602    246,501        7,101,299
Gaurav Shah, M.D.            41,608,251   6,800,852       7,101,299
David P. Southwell           36,115,931   12,293,172      7,101,299
Roderick Wong, M.D.          40,759,519   7,649,584       7,101,299
Naveen Yalamanchi, M.D.      36,921,225   11,487,878      7,101,299

Proposal Two - Ratification of Appointment of Independent Registered Accounting Firm

The Company's stockholders ratified the appointment of EisnerAmper LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2022 by the following votes:



Votes For    Votes Against   Abstentions
55,475,923      30,029          4,450

Proposal Three - Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers

The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement for the 2022 Annual Meeting of Stockholders pursuant to Section 14A of the Exchange Act, including the Compensation Discussion and Analysis, the Summary Compensation Table, and the narrative disclosures that accompany the compensation tables. The final votes were:



Votes For    Votes Against   Abstentions   Broker Non-Votes
42,160,877     6,240,249        7,977         7,101,299

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses